A comparative study of confidence intervals to assess biosimilarity from analytical data

Pharm Stat. 2019 May;18(3):316-328. doi: 10.1002/pst.1925. Epub 2019 Jan 15.

Abstract

Assessment of analytical similarity of tier 1 quality attributes is based on a set of hypotheses that tests the mean difference of reference and test products against a margin adjusted for standard deviation of the reference product. Thus, proper assessment of the biosimilarity hypothesis requires statistical tests that account for the uncertainty associated with the estimations of the mean differences and the standard deviation of the reference product. Recently, a linear reformulation of the biosimilarity hypothesis has been proposed, which facilitates development and implementation of statistical tests. These statistical tests account for the uncertainty in the estimation process of all the unknown parameters. In this paper, we survey methods for constructing confidence intervals for testing the linearized reformulation of the biosimilarity hypothesis and also compare the performance of the methods. We discuss test procedures using confidence intervals to make possible comparison among recently developed methods as well as other previously developed methods that have not been applied for demonstrating analytical similarity. A computer simulation study was conducted to compare the performance of the methods based on the ability to maintain the test size and power, as well as computational complexity. We demonstrate the methods using two example applications. At the end, we make recommendations concerning the use of the methods.

Keywords: Howe's method; Wald-type confidence intervals; biosimilarity; confidence interval; exact-based intervals; generalized confidence intervals.

Publication types

  • Comparative Study

MeSH terms

  • Biosimilar Pharmaceuticals* / therapeutic use
  • Computer Simulation / statistics & numerical data*
  • Confidence Intervals*
  • Humans

Substances

  • Biosimilar Pharmaceuticals